Last reviewed · How we verify

Sodium Copper Chlorophyllin

Tata Memorial Centre · Phase 2 active Small molecule

Sodium Copper Chlorophyllin is a Small molecule drug developed by Tata Memorial Centre. It is currently in Phase 2 development.

At a glance

Generic nameSodium Copper Chlorophyllin
SponsorTata Memorial Centre
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Sodium Copper Chlorophyllin

What is Sodium Copper Chlorophyllin?

Sodium Copper Chlorophyllin is a Small molecule drug developed by Tata Memorial Centre.

Who makes Sodium Copper Chlorophyllin?

Sodium Copper Chlorophyllin is developed by Tata Memorial Centre (see full Tata Memorial Centre pipeline at /company/tata-memorial-centre).

What development phase is Sodium Copper Chlorophyllin in?

Sodium Copper Chlorophyllin is in Phase 2.

Related